LFWD — Lifeward Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1607962 ·
Last close
$3.10
Market Cap
$8.80M
52W High
$9.61
52W Low
$3.10
ADV30
18,661
Next earnings
2026-11-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 6,623,000 | 2,709,000 | -4,152,000 | -11,519,000 | 35,000,000 | 9,448,000 | 22,784,000 |
| Mar 2026 | 3,923,000 | 1,342,000 | -10,339,000 | -10,793,000 | 33,419,000 | 11,422,000 | 27,128,000 |
| Dec 2025 | 5,081,000 | 1,088,000 | -5,118,000 | -5,348,000 | 22,900,000 | 2,169,000 | 14,492,000 |
| Sep 2025 | 6,195,000 | 2,707,000 | -3,140,000 | -3,170,000 | 23,168,000 | 1,956,000 | 10,413,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-17,077,000
Investing CF
$6,461,000
Financing CF
$14,929,000
CapEx
$-16,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-16.82
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-307,051,000
Inventory
$6,151,000
Receivables
$8,365,000
ST Investments
—
EBIT TTM
$-29,268,000
Pretax Income TTM
$-30,880,000
Interest Exp TTM
$1,286,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$21,822,000
EBITDA
$-22,982,000
Free Cash Flow
$-7,994,125
Enterprise Value
$9,038,551
Total Cash
$9,448,000
Total Debt
$6,988,000
Shares Out
2,838,715
Trailing EPS
$-15.73
Book Value
$5.52
ROE
-225.6%
ROA
-47.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 22,034,000 | -16,891,000 | -19,914,000 | 22,900,000 | 14,492,000 | 8,408,000 | -16,826,000 |
| Dec 2024 | 25,663,000 | -19,553,000 | -28,942,000 | 30,487,000 | 11,638,000 | 18,849,000 | -21,718,000 |
| Dec 2023 | 13,854,000 | -23,612,000 | -22,133,000 | 63,192,000 | 16,682,000 | 46,510,000 | -20,667,000 |
| Dec 2022 | 5,511,000 | -19,102,000 | -19,569,000 | 74,236,000 | 6,071,000 | 68,165,000 | -17,891,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$21,822,000
NetIncome TTM
$-30,830,000
OpCashFlow TTM
—
Assets (Latest)
$35,000,000
Forward EPS
$-0.86
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PLSM | Pulsenmore Ltd. | $8.78M | $1.35 | — |
| RGNT | REGENTIS BIOMATERIALS LTD. | $8.57M | $1.22 | — |
| SINT | Sintx Technologies, Inc. | $9.22M | $1.22 | — |
| GTHP | GUIDED THERAPEUTICS INC | $8.30M | $0.09 | — |
| FEMY | FEMASYS INC | $9.38M | $1.12 | — |
News headlines (Yahoo Finance, 1h cache)
Lifeward: Q3 Earnings Snapshot
2026-11-13 14:26 · Yahoo
Lifeward (LFWD) Reports Q3 Loss, Misses Revenue Estimates
2026-11-13 14:25 · Yahoo
Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-13 14:16 · Yahoo
Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study
2026-10-14 12:00 · Yahoo
Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
2026-09-15 12:00 · Yahoo
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
2026-09-08 12:30 · Yahoo
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer
2026-08-31 20:15 · Yahoo
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
2026-08-07 12:00 · Yahoo
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
2026-08-05 12:00 · Yahoo
BioStem Technologies, Inc. (BSEM) Reports Q3 Loss, Beats Revenue Estimates
2026-11-12 22:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.